Search company, investor...

SICOR

Founded Year

1986

Stage

IPO | IPO

Total Raised

$41.4M

Date of IPO

6/5/1990

About SICOR

Developer of therapeutic drugs based on research in purine/pyrimidine metabolism for treatment of cardiovascular, cerebrovascular, neurological and inflammatory diseases. Also research and development in catecholamine analogues. The first product from this program combines a novel drug with a proprietary, computer-controlled, non-invasive delivery system to enhance the diagnosis, prognosis and management of cardiovascular disease significantly. As of January 1990, there are two drugs in phase II clinical trials in Europe. They are ARA (adenosine regulating agent) and ESA (exercise stimulating agent). The IND for ARA has been filed with the FDA. Company anticipates that both drugs will be available in Europe by mid-1993 and in the United States by mid-1994.

Headquarters Location

11075 Roselle Street

San Diego, California, 92121,

United States

(619)546-8300

Missing: SICOR's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SICOR's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SICOR Patents

SICOR has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/23/2016

8/1/2017

Experimental cancer drugs, Dicarboxylic acids, Monoclonal antibodies, Amino acids, Monoclonal antibodies for tumors

Grant

Application Date

11/23/2016

Grant Date

8/1/2017

Title

Related Topics

Experimental cancer drugs, Dicarboxylic acids, Monoclonal antibodies, Amino acids, Monoclonal antibodies for tumors

Status

Grant

SICOR Frequently Asked Questions (FAQ)

  • When was SICOR founded?

    SICOR was founded in 1986.

  • Where is SICOR's headquarters?

    SICOR's headquarters is located at 11075 Roselle Street, San Diego.

  • What is SICOR's latest funding round?

    SICOR's latest funding round is IPO.

  • How much did SICOR raise?

    SICOR raised a total of $41.4M.

  • Who are the investors of SICOR?

    Investors of SICOR include Marion Merrell Dow, Kleiner Perkins Caufield & Byers, Aspen Ventures, Biotechnology Investments, Fairfield and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.